Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs. Update 2014

Manuscript Number: 

14-1206R1

Author(s): 
Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer

Disclosures

Wolfgang Froestl

  • Equity:
    AC Immune SA
    Sponsors:
    AC Immune SA
    Patents/Royalties
    AC Immune SA

Andreas Muhs

  • Equity:
    AC Immune SA
    Sponsors:
    AC Immune SA
    Patents/Royalties
    AC Immune SA

Andrea Pfeifer

  • Equity:
    Ac Immune SA
    Sponsors:
    AC Immune SA
    Patents/Royalties
    AC Immune SA